• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期前列腺癌:老年患者的最佳治疗方法。

Locally advanced prostate cancer: optimal therapy in older patients.

机构信息

Department of Urology, University Hospital "Carl Gustav Carus", Dresden University of Technology, Fetscherstrasse 74, 01304, Dresden, Germany,

出版信息

Drugs Aging. 2013 Dec;30(12):959-67. doi: 10.1007/s40266-013-0123-7.

DOI:10.1007/s40266-013-0123-7
PMID:24097331
Abstract

There is no standard treatment for locally advanced prostate cancer. Even the definition is still unclear. Locally advanced disease may refer to over-staged well-curable tumors as well as to advanced and probably incurable cancers. Similar uncertainties are present regarding the definition of 'old' in this context. Conservatively treated locally advanced prostate cancer is associated with poor survival outcome. With the increasing life expectancy, in the absence of curative treatment, even patients in their ninth decade of life may later suffer from symptoms of aggressive prostate cancer and are at a high risk of death from prostate cancer that might be prevented at least in part by early intervention. On the other hand, functional results after prostate cancer treatment are worse in elderly patients. In this article we discuss aspects of the management of locally advanced prostate cancer in the elderly with special focus on the recommendation of current clinical guidelines.

摘要

局部晚期前列腺癌尚无标准治疗方法。即使是定义也仍不明确。局部晚期疾病可能是指分期过高但仍可治愈的肿瘤,以及晚期且可能无法治愈的癌症。在这种情况下,“老”的定义也存在类似的不确定性。局部晚期前列腺癌的保守治疗与不良生存结果相关。随着预期寿命的增加,在缺乏治愈性治疗的情况下,即使是 90 多岁的患者,以后也可能出现侵袭性前列腺癌的症状,并且死于前列腺癌的风险很高,这种风险至少可以部分通过早期干预来预防。另一方面,老年患者前列腺癌治疗后的功能结果更差。在本文中,我们讨论了老年局部晚期前列腺癌的治疗管理方面的问题,特别关注当前临床指南的建议。

相似文献

1
Locally advanced prostate cancer: optimal therapy in older patients.局部晚期前列腺癌:老年患者的最佳治疗方法。
Drugs Aging. 2013 Dec;30(12):959-67. doi: 10.1007/s40266-013-0123-7.
2
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.局部晚期前列腺癌男性患者的短期雄激素抑制和放疗与中期雄激素抑制和放疗,联合或不联合唑来膦酸治疗(TROG 03.04 RADAR):一项随机、3 期、析因试验的 10 年结果。
Lancet Oncol. 2019 Feb;20(2):267-281. doi: 10.1016/S1470-2045(18)30757-5. Epub 2018 Dec 19.
3
[The role of surgery in locally advanced prostate cancer].[手术在局部晚期前列腺癌中的作用]
Urologe A. 2008 Nov;47(11):1417-23. doi: 10.1007/s00120-008-1721-6.
4
Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer.局部晚期及临床局限性前列腺癌的放射治疗与激素治疗
Urology. 2002 Sep;60(3 Suppl 1):32-7; discussion 37-8. doi: 10.1016/s0090-4295(02)01566-2.
5
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.病理分期晚期前列腺癌的辅助放疗:一项随机临床试验。
JAMA. 2006 Nov 15;296(19):2329-35. doi: 10.1001/jama.296.19.2329.
6
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.局部晚期前列腺癌的短期新辅助雄激素剥夺和放疗:来自 TROG 96.01 随机试验的 10 年数据。
Lancet Oncol. 2011 May;12(5):451-9. doi: 10.1016/S1470-2045(11)70063-8.
7
[Preliminary results of radical surgery and radiotherapy of locally advanced prostate cancer (basal PSA >50 ng/ml)].[局部晚期前列腺癌(基础前列腺特异性抗原>50 ng/ml)的根治性手术及放疗初步结果]
Vopr Onkol. 2007;53(4):479-81.
8
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.辅助治疗初治患者根治性前列腺切除术后切缘阳性对前列腺特异抗原失败的影响。
BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.
9
[The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].[采用根治性前列腺切除术或放射疗法治疗局部晚期(T3期)前列腺癌。综述]
Tijdschr Gerontol Geriatr. 1998 Apr;29(2):74-9.
10
Feasibility of minimally invasive radical prostatectomy in prostate cancer patients with high prostate-specific antigen: feasibility and 1-year outcomes.高前列腺特异性抗原前列腺癌患者微创根治性前列腺切除术的可行性:可行性和 1 年结果。
Int J Urol. 2012 Oct;19(10):923-7. doi: 10.1111/j.1442-2042.2012.03068.x. Epub 2012 Jul 4.

引用本文的文献

1
[Organ and function preservation in prostate cancer].[前列腺癌的器官与功能保留]
Urologe A. 2014 Sep;53(9):1295-301. doi: 10.1007/s00120-014-3526-0.
2
Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.老年前列腺癌男性患者先天性和适应性免疫系统的衰老重塑
Curr Gerontol Geriatr Res. 2014;2014:478126. doi: 10.1155/2014/478126. Epub 2014 Mar 19.

本文引用的文献

1
Long-term functional outcomes after treatment for localized prostate cancer.局限性前列腺癌治疗后的长期功能结局。
N Engl J Med. 2013 Jan 31;368(5):436-45. doi: 10.1056/NEJMoa1209978.
2
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
3
[Elderly prostate cancer patients: patient information and shared decision making].[老年前列腺癌患者:患者信息与共同决策]
Urologe A. 2013 Jun;52(6):847-52. doi: 10.1007/s00120-012-3071-7.
4
Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart.对于 70 岁以上的前列腺癌患者,与年龄相匹配的年轻患者相比,接受根治性前列腺切除术治疗的患者生化复发率更高。
Prostate. 2013 Jun;73(8):897-903. doi: 10.1002/pros.22635. Epub 2012 Dec 31.
5
Perioperative complications of radical retropubic prostatectomy in patients with locally advanced prostate cancer: a comparison with clinically localized prostate cancer.根治性耻骨后前列腺切除术治疗局部晚期前列腺癌的围手术期并发症:与临床局限性前列腺癌的比较。
Asian J Androl. 2013 Mar;15(2):241-5. doi: 10.1038/aja.2012.120. Epub 2012 Dec 10.
6
Prostate cancer in younger and older patients: do we treat them differently?年轻和老年患者的前列腺癌:我们对他们的治疗方式不同吗?
Asian Pac J Cancer Prev. 2012;13(9):4577-80. doi: 10.7314/apjcp.2012.13.9.4577.
7
Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.≥70 岁患者行根治性前列腺切除术的肿瘤特征、肿瘤学和功能结局。
BJU Int. 2013 Mar;111(3 Pt B):E24-9. doi: 10.1111/j.1464-410X.2012.11368.x. Epub 2012 Sep 5.
8
20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.根治性前列腺切除术治疗 cT3 前列腺癌 20 年生存。
BJU Int. 2012 Dec;110(11):1709-13. doi: 10.1111/j.1464-410X.2012.11372.x. Epub 2012 Aug 30.
9
Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound.前列腺癌的局部分期:T2 加权直肠内磁共振成像和经直肠超声的比较准确性。
Clin Imaging. 2012 Sep-Oct;36(5):547-52. doi: 10.1016/j.clinimag.2011.11.028. Epub 2012 Jun 8.
10
Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b).局部进展期前列腺癌(T2c-T3b)冷冻消融与外照射放疗随机对照临床试验的长期肿瘤学随访结果。
J Urol. 2012 Oct;188(4):1170-5. doi: 10.1016/j.juro.2012.06.014. Epub 2012 Aug 15.